ALNY
Price
$452.00
Change
-$1.54 (-0.34%)
Updated
Sep 5 closing price
Capitalization
59.25B
47 days until earnings call
AVTX
Price
$11.60
Change
+$1.44 (+14.17%)
Updated
Sep 5 closing price
Capitalization
152.57M
Interact to see
Advertisement

ALNY vs AVTX

Header iconALNY vs AVTX Comparison
Open Charts ALNY vs AVTXBanner chart's image
Alnylam Pharmaceuticals
Price$452.00
Change-$1.54 (-0.34%)
Volume$751.5K
Capitalization59.25B
Avalo Therapeutics
Price$11.60
Change+$1.44 (+14.17%)
Volume$363.34K
Capitalization152.57M
ALNY vs AVTX Comparison Chart in %
Loading...
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALNY vs. AVTX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a StrongBuy and AVTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ALNY: $452.00 vs. AVTX: $11.60)
Brand notoriety: ALNY and AVTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 68% vs. AVTX: 152%
Market capitalization -- ALNY: $59.25B vs. AVTX: $152.57M
ALNY [@Biotechnology] is valued at $59.25B. AVTX’s [@Biotechnology] market capitalization is $152.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 1 FA rating(s) are green whileAVTX’s FA Score has 1 green FA rating(s).

  • ALNY’s FA Score: 1 green, 4 red.
  • AVTX’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALNY and AVTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 3 TA indicator(s) are bullish while AVTX’s TA Score has 5 bullish TA indicator(s).

  • ALNY’s TA Score: 3 bullish, 4 bearish.
  • AVTX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, AVTX is a better buy in the short-term than ALNY.

Price Growth

ALNY (@Biotechnology) experienced а +1.23% price change this week, while AVTX (@Biotechnology) price change was +24.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

ALNY is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALNY($59.2B) has a higher market cap than AVTX($153M). ALNY YTD gains are higher at: 92.087 vs. AVTX (56.124). AVTX has higher annual earnings (EBITDA): -59.78M vs. ALNY (-170.84M). ALNY has more cash in the bank: 2.86B vs. AVTX (113M). AVTX has less debt than ALNY: AVTX (679K) vs ALNY (1.3B). ALNY has higher revenues than AVTX: ALNY (2.46B) vs AVTX (441K).
ALNYAVTXALNY / AVTX
Capitalization59.2B153M38,693%
EBITDA-170.84M-59.78M286%
Gain YTD92.08756.124164%
P/E RatioN/A1.77-
Revenue2.46B441K558,277%
Total Cash2.86B113M2,529%
Total Debt1.3B679K191,016%
FUNDAMENTALS RATINGS
ALNY vs AVTX: Fundamental Ratings
ALNY
AVTX
OUTLOOK RATING
1..100
8482
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
8100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
3736
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVTX's Valuation (85) in the Pharmaceuticals Other industry is in the same range as ALNY (96) in the Biotechnology industry. This means that AVTX’s stock grew similarly to ALNY’s over the last 12 months.

ALNY's Profit vs Risk Rating (8) in the Biotechnology industry is significantly better than the same rating for AVTX (100) in the Pharmaceuticals Other industry. This means that ALNY’s stock grew significantly faster than AVTX’s over the last 12 months.

AVTX's SMR Rating (99) in the Pharmaceuticals Other industry is in the same range as ALNY (100) in the Biotechnology industry. This means that AVTX’s stock grew similarly to ALNY’s over the last 12 months.

AVTX's Price Growth Rating (36) in the Pharmaceuticals Other industry is in the same range as ALNY (37) in the Biotechnology industry. This means that AVTX’s stock grew similarly to ALNY’s over the last 12 months.

AVTX's P/E Growth Rating (1) in the Pharmaceuticals Other industry is significantly better than the same rating for ALNY (100) in the Biotechnology industry. This means that AVTX’s stock grew significantly faster than ALNY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALNYAVTX
RSI
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
64%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 10 days ago
86%
Declines
ODDS (%)
Bearish Trend 8 days ago
64%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BDCC0.080.02
+25.76%
Blackwell 3D Construction Corp.
WTCHF62.01N/A
N/A
Wisetech Global
SOOBF42.10N/A
N/A
Sapporo Holdings, Ltd.
VARXF0.82N/A
N/A
BOE Varitronix Ltd.
GELNF0.12N/A
N/A
GELION PLC

ALNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with ARGX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then ARGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALNY
1D Price
Change %
ALNY100%
-0.34%
ARGX - ALNY
50%
Loosely correlated
+2.33%
IONS - ALNY
46%
Loosely correlated
+3.17%
DNLI - ALNY
39%
Loosely correlated
+4.33%
INSM - ALNY
39%
Loosely correlated
+1.80%
AXSM - ALNY
37%
Loosely correlated
+0.61%
More

AVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTX has been loosely correlated with FGEN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AVTX jumps, then FGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTX
1D Price
Change %
AVTX100%
+14.17%
FGEN - AVTX
57%
Loosely correlated
+6.98%
LIANY - AVTX
39%
Loosely correlated
+0.94%
ALNY - AVTX
30%
Poorly correlated
-0.34%
VTGN - AVTX
30%
Poorly correlated
-1.93%
MGTX - AVTX
29%
Poorly correlated
-0.39%
More